Are you sure you want to exit?
Any unsave changes will be lost.
Kamada
Laboratory
Israel, Asia
Kamada is developing anti coronavirus polyclonal immunoglobulin treatment for severely ill COVID- 19 patients.
https://www.kamada.com/news/kamada-provides-update-on-progress-related-to-its-proprietary-hyper-immunoglobulin-iggs-platform-technology-including-its-commercial-anti-rabies-igg-and-its-pipeline-products-anti-corona-covid-19/